Hemodynamically-guided management using an implanted pulmonary artery pressure sensor is indicated to reduce heart failure (HF) hospitalizations in patients with New York Heart Association (NYHA) functional class II-III with a prior HF hospitalization or those with elevated natriuretic peptides.
Editors
Editor-in-Chief Christopher O’Connor, MD, FACC
Executive Editor Mona Fiuzat, PharmD, FACC
JACC Heart Failure CME Editors Tariq Ahmad, MD, MPH Adam DeVore, MDAbhinav Sharma, MDMitchell Psotka, MD, PhDKishan Parikh, MD
AuthorMichael H. Beasley, MD
Important Dates
Date of Release: November 28, 2022Term of Approval/Date of CME/MOC/ECME Expiration: November 27, 2023